{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:47:59Z","timestamp":1791748079121,"version":"4.3.4"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T00:00:00Z","timestamp":1785283200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020624","name":"NIHR Nottingham Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203310"],"award-info":[{"award-number":["NIHR203310"]}],"id":[{"id":"10.13039\/501100020624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-hepatology.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Hepatology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jhep.2026.07.023","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T06:37:37Z","timestamp":1785911857000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Corticosteroid therapy for drug-induced liver injury: Mind the gap!"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3924-4830","authenticated-orcid":false,"given":"Guruprasad P.","family":"Aithal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7077-8078","authenticated-orcid":false,"given":"Sabine","family":"Weber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5378-6076","authenticated-orcid":false,"given":"Hester","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhep.2026.07.023_bib1","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/liv.15378","article-title":"A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry","volume":"43","author":"Bjornsson","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.07.023_bib2","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.jhep.2016.12.003","article-title":"EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure","volume":"66","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib3","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s40264-021-01109-4","article-title":"Drug-induced liver injury: highlights and controversies in the recent literature","volume":"44","author":"Clinton","year":"2021","journal-title":"Drug Saf"},{"key":"10.1016\/j.jhep.2026.07.023_bib4","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/hep.29283","article-title":"Death and liver transplantation within 2 years of onset of drug-induced liver injury","volume":"66","author":"Hayashi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.07.023_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.jhep.2023.04.033","article-title":"Nomenclature, diagnosis and management of drug-induced autoimmune-like hepatitis (DI-ALH): an expert opinion meeting report","volume":"79","author":"Andrade","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib6","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.annonc.2022.10.001","article-title":"Management of toxicities from immunotherapy: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up","volume":"33","author":"Haanen","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jhep.2026.07.023_bib7","doi-asserted-by":"crossref","first-page":"4073","DOI":"10.1200\/JCO.21.01440","article-title":"Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: asco guideline update","volume":"39","author":"Schneider","year":"2021","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jhep.2026.07.023_bib8","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1002\/hep.32689","article-title":"AASLD practice guidance on drug, herbal, and dietary supplement-induced liver injury","volume":"77","author":"Fontana","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.07.023_bib9","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1053\/j.gastro.2019.01.034","article-title":"A missense variant in PTPN22 is a risk factor for drug-induced liver injury","volume":"156","author":"Cirulli","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.07.023_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1016\/j.jhep.2018.05.013","article-title":"Pharmacogenomics of drug-induced liver injury (DILI): molecular biology to clinical applications","volume":"69","author":"Kaliyaperumal","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib11","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1053\/j.gastro.2022.11.036","article-title":"Identification of reduced ERAP2 expression and a novel HLA allele as components of a risk score for susceptibility to liver injury due to amoxicillin-clavulanate","volume":"164","author":"Nicoletti","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhep.2026.07.023_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-014178","article-title":"Circulating exhausted CD8+ effector memory cells differentiate immune checkpoint inhibitor-induced liver injury from other acute immune-mediated liver injuries","volume":"14","author":"Astbury","year":"2026","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.jhep.2026.07.023_bib13","series-title":"Corticosteroid adverse effects. StatPearls [Internet]","author":"Yasir","year":"2025"},{"key":"10.1016\/j.jhep.2026.07.023_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/cells10102529","article-title":"Acquired glucocorticoid resistance due to homologous glucocorticoid receptor downregulation: a modern look at an age-old problem","volume":"10","author":"Spies","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.jhep.2026.07.023_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/sj.bjp.0706736","article-title":"How corticosteroids control inflammation: quintiles prize lecture 2005","volume":"148","author":"Barnes","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jhep.2026.07.023_bib16","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.tips.2018.11.002","article-title":"Non-genomic effects of glucocorticoids: an updated view","volume":"40","author":"Panettieri","year":"2019","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jhep.2026.07.023_bib17","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.3389\/fimmu.2019.01591","article-title":"Glucocorticoids shape macrophage phenotype for tissue repair","volume":"10","author":"Desgeorges","year":"2019","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.07.023_bib18","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jhep.2019.11.013","article-title":"Interleukin-22 ameliorates acute-on-chronic liver failure by reprogramming impaired regeneration pathways in mice","volume":"72","author":"Xiang","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI155880","article-title":"Corticosteroids impair epithelial regeneration in immune-mediated intestinal damage","volume":"134","author":"Arnhold","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jhep.2026.07.023_bib20","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(09)60326-3","article-title":"Glucocorticoid resistance in inflammatory diseases","volume":"373","author":"Barnes","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.jhep.2026.07.023_bib21","doi-asserted-by":"crossref","DOI":"10.1097\/HC9.0000000000000525","article-title":"Steroid-refractory immune checkpoint inhibitor (ICI) hepatitis and ICI rechallenge: a systematic review and meta-analysis","volume":"8","author":"Hwang","year":"2024","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhep.2026.07.023_bib22","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.anai.2025.03.009","article-title":"Elevated oxidative stress and steroid insensitivity in patients with asthma and high body fat percentage","volume":"134","author":"To","year":"2025","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jhep.2026.07.023_bib23","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1007\/s00262-017-2107-7","article-title":"Anti-PD-1-induced high-grade hepatitis associated with corticosteroid-resistant T cells: a case report","volume":"67","author":"McGuire","year":"2018","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jhep.2026.07.023_bib24","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1159\/000322298","article-title":"Steroid and ursodesoxycholic acid combination therapy in severe drug-induced liver injury","volume":"84","author":"Wree","year":"2011","journal-title":"Digestion"},{"key":"10.1016\/j.jhep.2026.07.023_bib25","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s12013-012-9373-y","article-title":"Hospital admissions for drug-induced liver injury: clinical features, therapy, and outcomes","volume":"64","author":"Hou","year":"2012","journal-title":"Cell Biochem Biophys"},{"key":"10.1016\/j.jhep.2026.07.023_bib26","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/1751-2980.12383","article-title":"Beneficial effect of corticosteroids for patients with severe drug-induced liver injury","volume":"17","author":"Hu","year":"2016","journal-title":"J Dig Dis"},{"key":"10.1016\/j.jhep.2026.07.023_bib27","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/liv.13538","article-title":"N-acetylcysteine and prednisolone treatment improved serum biochemistries in suspected flupirtine cases of severe idiosyncratic liver injury","volume":"38","author":"Borlak","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.07.023_bib28","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.jhep.2021.08.024","article-title":"Infliximab-induced liver injury: clinical phenotypes, autoimmunity and the role of corticosteroid treatment","volume":"76","author":"Bjornsson","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib29","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/hep.26678","article-title":"Steroid use in acute liver failure","volume":"59","author":"Karkhanis","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.07.023_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.clinre.2017.08.003","article-title":"Features and outcomes from a retrospective study of 570 hospitalized Chinese patients with drug-induced liver injury","volume":"42","author":"Pang","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"10.1016\/j.jhep.2026.07.023_bib31","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000015886","article-title":"Prednisone is not beneficial for the treatment of severe drug-induced liver injury","volume":"98","author":"Wan","year":"2019","journal-title":"Medicine"},{"key":"10.1016\/j.jhep.2026.07.023_bib32","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1016\/j.cgh.2018.12.035","article-title":"Predniso(lo)ne dosage and chance of remission in patients with autoimmune hepatitis","volume":"17","author":"Pape","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib33","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.iliver.2023.06.001","article-title":"Prednisolone therapy accelerates recovery of severe drug-induced liver injury: a prospective, randomized controlled study","volume":"2","author":"Song","year":"2023","journal-title":"ILIVER"},{"key":"10.1016\/j.jhep.2026.07.023_bib34","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1038\/clpt.2011.58","article-title":"Case definition and phenotype standardization in drug-induced liver injury","volume":"89","author":"Aithal","year":"2011","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.07.023_bib35","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/apt.16902","article-title":"Corticosteroid plus glycyrrhizin therapy for chronic drug- or herb-induced liver injury achieves biochemical and histological improvements: a randomised open-label trial","volume":"55","author":"Wang","year":"2022","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.07.023_bib36","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/liv.15899","article-title":"An optimized short-term steroid therapy for chronic drug-induced liver injury: a prospective randomized clinical trial","volume":"44","author":"Huang","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhep.2026.07.023_bib37","article-title":"Incidence, risk factors and outcomes of checkpoint inhibitor-induced liver injury: a 10-year real-world retrospective cohort study","volume":"5","author":"Atallah","year":"2023","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhep.2026.07.023_bib38","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.jhep.2018.03.034","article-title":"Immune-related hepatitis with immunotherapy: are corticosteroids always needed?","volume":"69","author":"Gauci","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib39","doi-asserted-by":"crossref","first-page":"251","DOI":"10.14309\/ajg.0000000000000398","article-title":"Clinical characteristics and adverse impact of hepatotoxicity due to immune checkpoint inhibitors","volume":"115","author":"Miller","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhep.2026.07.023_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/hep.32215","article-title":"Effect of corticosteroid dosing on outcomes in high-grade immune checkpoint inhibitor hepatitis","volume":"75","author":"Li","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhep.2026.07.023_bib41","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1111\/apt.17898","article-title":"An algorithm based on immunotherapy discontinuation and liver biopsy spares corticosteroids in two thirds of cases of severe checkpoint inhibitor-induced liver injury","volume":"59","author":"Riveiro-Barciela","year":"2024","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhep.2026.07.023_bib42","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41379-020-00653-1","article-title":"Liver biopsy findings in patients on immune checkpoint inhibitors","volume":"34","author":"Cohen","year":"2021","journal-title":"Mod Pathol"},{"key":"10.1016\/j.jhep.2026.07.023_bib43","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12113751","article-title":"Histological characteristics and management of hepatitis on immune checkpoint inhibitors: a retrospective descriptive study","volume":"12","author":"Parlati","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhep.2026.07.023_bib44","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1679328","article-title":"Case report of immune checkpoint inhibitor induced cholestatic hepatitis, acute renal injury and asymptomatic pancreatic enzyme elevation simultaneously","volume":"16","author":"Jiao","year":"2025","journal-title":"Front Immunol"},{"key":"10.1016\/j.jhep.2026.07.023_bib45","doi-asserted-by":"crossref","DOI":"10.3390\/curroncol32120663","article-title":"Steroid-refractory cholestatic immune-mediated hepatitis following nivolumab therapy in an elderly patient with metastatic melanoma: a rare and challenging presentation","volume":"32","author":"Posado-Dominguez","year":"2025","journal-title":"Curr Oncol"},{"key":"10.1016\/j.jhep.2026.07.023_bib46","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0253070","article-title":"Evaluation of liver enzyme elevations and hepatotoxicity in patients treated with checkpoint inhibitor immunotherapy","volume":"16","author":"Cunningham","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.jhep.2026.07.023_bib47","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/TCRM.S514868","article-title":"The higher incidence of liver injury in HCC patients compared to other malignancies during immune-checkpoint inhibitor therapy is primarily due to tumor progression","volume":"21","author":"Wang","year":"2025","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/j.jhep.2026.07.023_bib48","doi-asserted-by":"crossref","first-page":"5993","DOI":"10.1158\/1078-0432.CCR-21-1283","article-title":"Early use of high-dose glucocorticoid for the management of irAE is associated with poorer survival in patients with advanced melanoma treated with anti-PD-1 monotherapy","volume":"27","author":"Bai","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.jhep.2026.07.023_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.40695","article-title":"Survival among veterans receiving steroids for immune-related adverse events after immune checkpoint inhibitor therapy","volume":"6","author":"Van Buren","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jhep.2026.07.023_bib50","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/d41586-025-01379-3","article-title":"Make science more collegial: why the time for 'adversarial collaboration' has come","volume":"641","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.jhep.2026.07.023_bib51","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/MEG.0000000000002334","article-title":"Acute liver injury following methylprednisolone pulse therapy: 13 cases from a prospectively collected cohort","volume":"34","author":"Allgeier","year":"2022","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/j.jhep.2026.07.023_bib52","unstructured":"Available from: https:\/\/www.edge.org\/adversarial-collaboration-daniel-kahneman."}],"container-title":["Journal of Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826027510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168827826027510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T19:22:28Z","timestamp":1791746548000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168827826027510"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":52,"alternative-id":["S0168827826027510"],"URL":"https:\/\/doi.org\/10.1016\/j.jhep.2026.07.023","relation":{},"ISSN":["0168-8278"],"issn-type":[{"value":"0168-8278","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Corticosteroid therapy for drug-induced liver injury: Mind the gap!","name":"articletitle","label":"Article Title"},{"value":"Journal of Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhep.2026.07.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver.","name":"copyright","label":"Copyright"}]}}